Stephanie Lovell

Insider Reports History

Entity
Individual
Location
C/O Cyclerion Therapeutics, Inc., 301 Binney Street, Cambridge, MA
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephanie Lovell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TransMedics Group, Inc. Director Common Stock 1.93K $262K $136.26 May 23, 2024 Direct
Cyclerion Therapeutics, Inc. Director Stock Option (Right to Buy) 20K Jun 14, 2022 Direct
TransMedics Group, Inc. Director Stock Option (Right to Buy) 1.15K May 23, 2024 Direct

Insider Reports Filed by Stephanie Lovell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TMDX TransMedics Group, Inc. May 23, 2024 2 $0 4 May 28, 2024 Director
TMDX TransMedics Group, Inc. May 25, 2023 2 $0 4 May 30, 2023 Director
TMDX TransMedics Group, Inc. Nov 22, 2022 9 -$140K 4 Nov 23, 2022 Director
CYCN Cyclerion Therapeutics, Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
TMDX TransMedics Group, Inc. Jun 1, 2022 1 $0 4 Jun 6, 2022 Director
CYCN Cyclerion Therapeutics, Inc. Jun 24, 2021 1 $0 4 Jun 28, 2021 Director
TMDX TransMedics Group, Inc. May 27, 2021 1 $0 4 Jun 1, 2021 Director